Mankind Pharma and Innovent Biologics Partner to Launch Groundbreaking PD-1 Immunotherapy in India

Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies

Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio

Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases

European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC

Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal

EU Approval of Tagrisso Sets New Standard for EGFR-Mutated NSCLC Treatment

Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

Home
/
update
/
details

Mahajan Imaging & Labs Launches AI-Enhanced Advanced Cardiac Screening and Low-Dose Dual Energy Spectral CT Scanner for Comprehensive Imaging

NextEdge Admin

29 Jul 2024

2 min 17 sec

Mahajan Imaging & Labs, a leader in diagnostic services, has introduced a state-of-the-art Dual Energy Spectral CT scanner at their Gurugram centre. This advanced scanner ensures precise diagnoses across a range of medical conditions with a rotation speed of just 0.3 seconds, allowing quick scans without compromising image quality. A key benefit is the ultra-low-dose radiation, which is particularly advantageous for preventive cardiac scans and pediatric imaging. The AI-enabled software enhances early disease detection, especially in cardiac screening, and reduces radiation exposure for cardiac patients by up to 85%.

Dr. Harsh Mahajan, founder and chief radiologist, stated, "Our new dual-energy spectral CT scanner revolutionizes CT scanning by reducing scan times and radiation doses. This technology helps doctors identify heart diseases early and accurately." Dr. Shelly Mahajan, lab director and clinical lead, added, "This scanner is a step towards integrated diagnostics, offering advanced oncology tracking and CT-guided procedures for comprehensive diagnosis."

Mahajan Imaging & Labs operates high-end diagnostic centres across India, combining radiology, PET CT, genomics, pathology, and AI. They have pioneered technologies like Silent MRI, functional MRI, dual energy spectral CT, and 4D ultrasound. Their network includes 10 centres and 2 labs, with locations in Delhi NCR and prestigious hospitals like Sir Ganga Ram Hospital and Fortis Hospitals. Beyond clinical diagnostics, Mahajan Imaging & Labs is involved in advanced research with institutions such as MIT, Max Planck Institute, and AIIMS.